Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26
MWN-AI** Summary
At HIMSS26, Royal Philips showcased its advancements in patient monitoring and diagnostics, emphasizing the role of open, interoperable, AI-enabled platforms in enhancing care intelligence. The company's approach addresses the mounting pressures on healthcare systems, which struggle with growing data volumes and fragmented information leading to delayed care. According to Philips' Future Health Index 2025, a significant 77% of healthcare professionals have faced clinical time losses due to incomplete or inaccessible patient data.
Philips aims to bridge these knowledge gaps by integrating clinical signals with diagnostic insights, facilitating a shift towards continuous, actionable patient understanding. Their platforms connect various medical devices, monitoring systems, imaging platforms, and EMRs, enabling health systems to create a unified data foundation. This interconnectedness fosters visibility over patient data across diverse care settings, from high-acuity situations to post-discharge environments, ultimately enhancing decision-making and reducing workflow friction for healthcare teams.
The presentation highlighted two key capabilities: enterprise patient monitoring and Integrated Diagnostics. The former focuses on ensuring continuous visibility of physiological signals throughout the patient’s journey, which helps facilitate safe early discharges with oversight beyond hospital settings. Conversely, Integrated Diagnostics links disparate diagnostic systems across specialties, allowing clinicians quicker access to a comprehensive view of patient imaging and diagnostic data, thereby accelerating the time to diagnosis.
Philips underscores that their platform is designed with cybersecurity and responsible AI practices to ensure data liquidity while enhancing clinical decision-making. Overall, the showcased innovations reflect Philips' commitment to transforming fragmented care into a more cohesive, insight-driven experience that empowers clinicians to deliver better patient outcomes effectively.
MWN-AI** Analysis
At HIMSS26, Royal Philips presented a forward-thinking approach to patient care through its AI-enabled, interoperable platforms that connect patient monitoring and diagnostics. Philips’ emphasis on addressing the growing challenges in health systems—stemming from fragmented data and overwhelmed clinical capacities—positions the company favorably within the healthcare technology market.
Investors should recognize the operational efficiencies that Philips’ solutions promise. By reducing workflow friction and supporting clinical decision-making, Philips not only aims to improve patient outcomes but also increases the efficiency and capacity of healthcare providers. The integration of enterprise patient monitoring and Integrated Diagnostics can significantly lower the response time for interventions, which is critical in a fast-paced healthcare setting.
Considering the Future Health Index data suggesting that 77% of healthcare professionals experience lost clinical time due to data accessibility issues, there lies a substantial market opportunity for Philips. Implementing solutions that provide seamless data integration could facilitate better workflows, ultimately attracting a larger user base among health systems seeking to alleviate pressures and improve care quality.
Furthermore, Philips' commitment to cybersecurity and responsible AI enhances its value proposition in a sector increasingly wary of data breaches and ethical concerns. As health systems evolve toward a more connected infrastructure, companies that proactively address these concerns will likely see significant market advantage.
Given these dynamics, investors should monitor Philips as a long-term play in the health technology sector. With solid growth metrics, a comprehensive suite of solutions poised to unify care environments, and a proactive approach to emerging technologies, Philips stands at the forefront of reshaping the healthcare landscape. Future financial performance should benefit from the increasing reliance on integrated care intelligence across the industry.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
March 10, 2026
Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and across specialties. By connecting clinical signals with diagnostic information, Philips enables care teams to move from fragmented data to a more continuous, actionable understanding of the patient.
Health systems are under unprecedented pressure, with rapidly growing data volumes stretching clinical capacity and contributing to care delays. Delays are often compounded by fragmented data across monitoring systems, imaging platforms, and clinical applications. Philips’ Future Health Index 2025 found that 77% of healthcare professionals have lost clinical time due to issues with incomplete or inaccessible patient data [1]. As providers look for ways to expand capacity without adding burden, AI is increasingly being adopted to help automate routine tasks and surface relevant insights sooner. Yet scaling AI requires trusted, interoperable, longitudinal data that can be contextualized in clinical workflows.
Philips’ platforms are designed to connect data, devices, and teams across care settings and diagnostic domains. By linking medical devices, patient monitoring systems, imaging platforms, and health information systems – including EMR and third-party technologies – Philips enables health systems to create a unified data foundation that supports continuous visibility and longitudinal insight across the enterprise. At HIMSS26, Philips is showcasing two core capabilities that help make this connected care intelligence possible: enterprise patient monitoring that enables longitudinal care intelligence, and Integrated Diagnostics that brings imaging and diagnostic data together across the enterprise.
“Care is longitudinal – it doesn’t begin or end at the hospital door,” said Julia Strandberg, Chief Business Leader Connected Care at Royal Philips. “When data is connected across environments, clinicians can see a more continuous patient trajectory rather than disconnected snapshots. That broader context helps reduce noise, improve situational awareness, and allow care teams to focus their time on what matters most: earlier intervention and better patient outcomes.”
Enterprise patient monitoring – enabling longitudinal care intelligence
Across the acute and post-acute continuum, clinicians need continuous visibility that travels with the patient. Philips is advancing longitudinal care intelligence by connecting enterprise monitoring with interoperable clinical data – so physiologic signals remain visible as patients move across care settings, including in high-acuity environments, during transitions of care, and after discharge.
By integrating medical devices and health information systems, including EMRs and a broad ecosystem of third-party devices, Philips helps create a connected data thread with central monitoring and surveillance workflows that support clinical decision-making across encounters and over time. This longitudinal foundation can help reduce workflow friction for care teams. Connected monitoring can also support strategies to relieve pressure on high-acuity environments by supporting safe, early discharge with oversight beyond the hospital walls.
Integrated Diagnostics – enterprise imaging integration to help reduce workload
A complete patient story also depends on diagnostics. Yet in many hospitals, diagnostic imaging data live in disconnected systems across radiology, cardiology, pathology, and other specialties. Clinicians often navigate multiple viewers, logins, and workflows to access the information needed to make decisions.
Integrated Diagnostics connects diagnostic systems, workflows, and AI applications so clinicians can access a more unified view of patient imaging and diagnostic data when decisions cannot wait. Philips’ HealthSuite Integrated Diagnostics portfolio provides a comprehensive suite of cloud-based solutions designed to connect data, integrate workflows, and embed AI across the diagnostic enterprise.
“Integrated Diagnostics isn’t about adding another tool – it’s about connecting the diagnostic enterprise, so clinicians aren’t forced to assemble the story themselves,” said Shez Partovi, Chief Innovation Officer and Chief Business Leader of Enterprise Informatics at Royal Philips. “When cardiology, radiology, pathology and other diagnostic domains come together on a connected foundation, teams gain a more unified view of the patient, time to diagnosis can drop, and intelligence can be embedded into everyday workflows in a way that truly scales.”
Philips’ platform approach is built with cybersecurity, privacy, and responsible AI practices at its core. Trust is foundational to enabling data liquidity across the enterprise, supporting longitudinal context, and scaling AI in ways that strengthen clinical decision-making while minimizing unnecessary complexity.
Experience Philips at HIMSS26
At HIMSS26, Philips is demonstrating how enterprise patient monitoring and Integrated Diagnostics can reduce fragmentation, accelerate insight, and support confident action across care environments and diagnostic workflows – while giving clinicians time back to deliver better care. For more information about solutions highlighted at HIMSS26, visit here.
[1] Philips Future Health Index 2025. Available at: philips-future-health-index-2025-report-building-trust-in-healthcare-ai-global.pdf
For further information, please contact:
Anna Hogrebe
Philips Global External Relations
Tel.: +1 416 270 6757
E-mail: anna.hogrebe@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
FAQ**
How does "Koninklijke Philips NV RYLPF" plan to overcome the challenges of integrating AI capabilities with existing healthcare infrastructure to ensure seamless interoperability across various clinical systems by March 10, 2026?
What specific metrics does "Koninklijke Philips NV RYLPF" use to measure the success of their Integrated Diagnostics solution in improving patient outcomes and reducing decision-making time for clinicians by 2026?
In light of the HIMSS26 showcase, what partnerships is "Koninklijke Philips NV RYLPF" pursuing to enhance their open, interoperable, AI-enabled platforms in both Amsterdam and Las Vegas healthcare systems by March 2026?
How will "Koninklijke Philips NV RYLPF" address concerns regarding cybersecurity and privacy as they expand their enterprise patient monitoring and Integrated Diagnostics offerings through 2026 and beyond?
**MWN-AI FAQ is based on asking OpenAI questions about Koninklijke Philips N.V. NY Registry Shares (NYSE: PHG).
NASDAQ: PHG
PHG Trading
-1.83% G/L:
$27.94 Last:
328,762 Volume:
$28.40 Open:
